Inhibition of In Vitro Intracellular Growth of Trypanosoma cruzi by Dicationic Compounds

Journal of Parasitology

Volumn 89, Issue 5, 2003, Pages 1078-1080

  Rowland, Edwin C ^a   Moore Lai, Deborah ^a   Seed, John R ^b   Stephens, Chad E ^c   Boykin, David W ^c  

^a OHIO UNIVERSITY   (United States)

^b IL   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; DB 702; DB 709; DB 710; DB 712; DB 713; DB 745; PENTAMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

PARASITOLOGY; TRYPANOSOMIASIS;

ANTIPROTOZOAL ACTIVITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; DNA DRUG COMPLEX; DRUG EFFICACY; DRUG INHIBITION; EXTRACELLULAR SPACE; FIBROBLAST CULTURE; GROWTH INHIBITION; IC 50; INTRACELLULAR MEMBRANE; MICROBIAL GROWTH; NONHUMAN; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA CRUZI;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; HUMANS; MICE; MICE, INBRED BALB C; PENTAMIDINE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0345283305     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-53R     Document Type: Conference Paper

References (9)

1. CANCADO, J. R. 2002. Long term evaluation of etiological treatment of Chagas disease with Benznidazole. Revista do Instituto de Medicina Tropical de Sao Paulo 44: 29-37.
2. COURA, J. R., AND S. L. DECASTRO. 2002. A critical review on Chagas disease chemotherapy. Memorias do Instituto Oswaldo Cruz, Rio de Janeiro 97: 3-24.
3. FRAYHA, G. J., J. D. SMYTH, J. G. GOBERT, AND J. SAVEL. 1997. The mechanisms of action of antiprotozoal and anthelmintic drugs in man. General Pharmacology 28: 273-299.
4. LIRA, R., L. M. CONTRERAS, L. M. RITA, AND J. A. URBINA. 2001. Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: Potentiation of an in vitro activity by the sterol biosynthesis inhibitor ketoconazole. Journal of Antimicrobial Chemotherapy 47: 537-546.
5. PRATA, A. 2001. Clinical and epidemiological aspects of Chagas disease. The Lancet Infectious Diseases 1: 92-100.
6. ROWLAND, E., H. LUO, AND T. MCCORMICK. 1995. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence. Journal of Parasitology 81: 123-126.
7. STEPHENS, C. E., F. TANIOUS, S. KIM, W. D. WILSON, W. A. SCHELL, J. R. PERFECT, S. G. FRANZBLAU, AND D. W. BOYKIN. 2001. Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agents. Journal of Medicinal Chemistry 44: 1741-1748.
8. URBINA, J. A. 1999. Chemotherapy of Chagas' disease: The how and the why. Journal of Molecular Medicine 77: 332-338.
9. -, R. LIRA, G. VISBAL, AND J. BARTROLI. 2000. In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 44: 2498-2502.